133 - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 69; pp. S49 - S50
Main Authors	Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J.H., Zwaan, C.M., Marshall, L.V., Casanova, M., Branle, F., Malet, I., Emeremni, A.C., Geoerger, B.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.12.2016
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(16)32732-0